Intrauterine infection/inflammation during pregnancy and offspring brain damages: Possible mechanisms involved

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Huleihel, Mahmoud ^a   Golan, Hava ^a   Hallak, Mordechai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; APOPTOSIS INDUCING FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; EXCITATORY AMINO ACID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANGIOGENIC FACTOR;

ADULT; ANGIOGENESIS; BEHAVIOR DISORDER; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; DEVELOPMENTAL DISORDER; FEMALE; FETUS; FETUS DEVELOPMENT; HUMAN; INTELLECTUAL IMPAIRMENT; INTRAUTERINE INFECTION; MATERNAL DISEASE; MOUSE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY DISORDER; PROGENY; RAT; REVIEW; VASCULARIZATION; ANIMAL; APOPTOSIS; INFLAMMATION; METABOLISM; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; APOPTOSIS; BRAIN INJURIES; FEMALE; HUMANS; INFLAMMATION; NERVE GROWTH FACTORS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 4344710139     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-2-17     Document Type: Review

References (86)

1. Volpe JJ: Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Devel Disab Res Rev 2001, 7:56-64.
2. Berger R, Garnier Y, Jensen A: Perinatal brain damage: underlying mechanisms and neuroprotective strategies. J Soc Gynecol Investig 2002, 9:319-328.
3. Wu YW, Colford Jr JM: Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000, 284:1417-1424.
4. Pang Y, Cai Z, Rhodes PG: Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia. J Neurosci Res 2000, 62:510-520.
5. Garnier Y, Coumans ABC, Jensen A, Hassart THM, Berger R: Infection-related perinatal brain injury: the pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investing 2003, 10:450-459.
6. Schendel D, Schuchat A, Thorsen P: Public health issues related to infectionand pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002, 8:39-45.
7. Nyakas C, Buwalda B, Luiten PGM: Hypoxia and brain development. Prog Neurobiol 1996, 49:1-51.
8. Rickmann M, Wolff JR: Prenatal oligenesis in the neopallium of the rat. Adv Anat Embryol Cell Biol 1985, 93:1-10.
9. Sancho-Tello M, Valles S, Montoliu C, Renau-Piqueras J, Guerri C: Developmental pattern of GFAP and vimentin gene expression in rat brain and radial glial cultures. Glia 1995, 15:157-166.
10. Chamak B, Dobbertin A, Mallat M: Immunohistochemical detection of thrombospondin in microglia in the developing rat brain. Neuroscience 1995, 69:177-187.
11. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM: Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995, 346:1449-1454.
12. Zupan V, Gonzales P, Lacaze-Masmonteil T, Boithias C, d'Allest AM, Dehan M, Gabilan JC: Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 1996, 38:1061-1067.
13. Verma U, Tejani N, Klein S, Reale MR, Beneck D, Figueroa R, Visintainer P: Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. Am J Obstet Gynecol 1997, 176:275-281.
14. Berger R, Bender S, Sefkow S, Klingmüller V, Künzel W, Jensen A: Peri/intraventricular haemorrhage: A cranial ultrasound study on 5286 neonates. Eur J Obstet Gynecol Reprod Biol 1997, 75:191-203.
15. Dammann O, Leviton A: Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8.
16. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR: Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000, 182:675-681.
17. Gilles FH, Leviton A, Kerr CS: Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci 1976, 27:183-191.
18. Young RS, Yagel SK, Towfighi J: Systemic and neuropathologic effects of E. coli endotoxin in neonatal dogs. Pediatr Res 1983, 17:349-353.
19. Debillon T, Gras-Leguen C, Verielle V, Winer N, Caillon J, Roze J-C, Gressens P: Interauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000, 47:736-742.
20. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, Chi JG: Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997, 177:797-802.
21. Bunge RP: Glial cells and the central myelin sheath. Physiol Rev 1968, 48:197-251.
22. Jacobson L, Ek U, Fernell E, Flodmark O, Broberger U: Visual impairment in preterm children with periventricular leukomalacia-visual, cognitive and neuropediatric characteristics related to cerebral imaging. Dev Med Child Neurol 1996, 38:724-735.
23. Baerwald KD, Popko B: Developing and mature oligodendrocytes respond differently to immune cytokine interferon-γ. J Neurosci Res 1998, 52:230-239.
24. Helfaer MA, Kirsch JR, Traystman RJ: Radical scavengers: Penetration into brain following ischemia and reperfusion. In: Pharmacology of cerebral ischemia (Edited by: Krieglstein J, Oberpichler-Schwenk H). Medpharm Scientific, Stuttgart 1994, 297-309.
25. Palmer C, Towfighi J, Roberts RL, Heitjan DF: Allopurinol administered after inducing hypoxia/ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993, 33:405-411.
26. Saito K, Packianathan S, Longo LD: Free radical-induced elevation of ornithine decarboxylase activity in developing rat brain slices. Brain Res 1997, 763:232-238.
27. Banker BQ, Larroche JC: Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 1962, 7:386-610.
28. Maxwell WL, Follows R, Ashhurst DE, Berry M: The response of the cerebral hemisphere of the rat to injury: I. The mature rat. Philos Trans R Soc Lond Biol Sci 1990, 328:479-500.
29. Balasingam V, Tejada-Berges T, Wright E, Bouchova R, Yong VW: Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994, 14:846-856.
30. Deguchi K, Oguchi K, Takashima S: Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol 1997, 16:296-300.
31. Feldhaus B, Dietzel ID, Berger R: TNF-a induces cell death in primary cultures of oligodendrocyte progenitors. J Soc Gynecol Investig 2001, 8:248A.
32. Cai Z, Pan ZO, Pang Y, Evans OB, Rhodes PG: Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopoysacharide administration. Pediatr Res 2000, 47:64-72.
33. Merrill JE: Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992, 14:1-10.
34. Merrill JE: The effects of IL-1 and TNF alpha on astrocytes, microglia, oligodendrocytes and glial precursors in vitro. Dev Neurosci 1991, 13:130-137.
35. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB: Interleukin-1 is an astroglial growth factor in developing nervous system. J Neurosci 1988, 8:709-714.
36. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG: High expression of tumor necrosis factor-a and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynocol 1997, 177:406-411.
37. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi J-H, Kim I-O: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-a), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997, 177:19-26.
38. Megyeri P, Abraham CS, Temesvari P, Kovacs J, Vas T, Speer CP: Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992, 148:137-140.
39. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M: Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 1997, 17:491-499.
40. Tureen J: Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of nitric oxide. J Clin Invest 1995, 95:1086-1091.
41. Duchini A, Govindarajan S, Santucci M, Zampi G, Hofman FM: Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med 1996, 44:474-482.
42. Botchkina GI, Geimonen E, Bilof ML, Villarreal O, Tracey KJ: Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med 1999, 5:372-381.
43. Bell MJ, Hallenbeck JM: Effects of intrauterine inflammation on developing rat brain. J Neurosci Res 2002, 70:570-579.
44. Cammer W: Effects of TNF-a on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000, 864:213-219.
45. Ladiwala U, Hewei L, Antel J, Nalbantoglu J: p53 induction by tumor necrosis factor -a and involvement of p53 in cell death of human oligodendrocytes. J Neurochem 1999, 73:605-611.
46. Berger R, Garnier Y, Pfeiffer D, Jensen A: Lipopolysaccharides do not alter metabolic disturbances in hippocampal slices of fetal guinea pigs after oxygen-glucose deprivation. Pediatr Res 2000, 48:531-535.
47. Kaukola T, Satyaraj E, Patel DD, Tchernev VT, Grimwade BG, Kingsmore SF, Koskela P, Vainionpaa L, Pihko H, Aarimaa T, Hallman M: Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 2004, 55:186-194.
48. Oppenheim RW, Prevette D, Yin QW: Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 1991, 251:1616-1618.
49. Knusel B, Rabin SJ, Hefti F: Regulated neurotrophin receptor responsiveness during neuronal migration and early differentiation. J Neurosci 1994, 14:1542-1554.
50. Han BH, Holtzman DM: BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
51. Kirschner PB, Jenkins BG, Schulz JB: NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Res 1996, 713:178-185.
52. Walton M, Connor B, Lawlor P, Young D, Sirimanne E, Gluckman P, Cole G, Dragunow M: Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev 1999, 29:137-168.
53. Schwartz JP, Nishiyama N: Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res Bull 1994, 35:403-407.
54. Kamiguchi H, Yoshida K, Sagoh M, Sasaki H, Inaba M, Wakamoto H, Otani M, Toya S: Release of ciliary neurotrophic factor from cultured astrocytes and its modulation by cytokines. Neurochem Res 1995, 20:1187-1193.
55. Kahn MA, de Vellis J: Growth factors in the CNS and their effects on oligodendroglia. Prog Brain Res 1995, 105:145-169.
56. Heinrich M, Gorath M, Landsberg CR: Neurotrophin-3(NT-3) modulates early differentiation of oligodendrocytes in rat brain cortical culture. Glia 1999, 28:244-255.
57. Patan S: Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000, 50:1-15.
58. Miquerol L, Langille BL, Nagy A: Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000, 127:3941-3946.
59. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
60. Taylor CM, Stevens H, Anthony FW, Wheeler T: Influence of hypoxia on vascular endothelial growth factor-derived cell lines: JEG, Jar and BeWo. Placenta 1997, 18:451-458.
61. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
62. Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989, 78:225-228.
63. Shichiri M, Marumo F, Hirata Y: Endothelin-B receptor-mediated suppression of endothelial apoptosis. J Cardiovasc Pharmacol 1998, 31:S138-S141.
64. Lee ME, de la Monte SM, Ng SC, Bloch KD, Quertermous T: Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest 1990, 86:141-147.
65. Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, Uemura H: Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 1993, 132:530-533.
66. Kuwaki T, Kurihara H, Cao WH, Kurihara Y, Unekawa M, Yazaki Y, Kumada M: Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog Neurobiol 1997, 51:545-579.
67. Yamashita K, Kataoka Y, Yamashita YS, Himeno A, Tsutsumi K, Niwa M, Taniyama K: Glial endothelin/nitric oxide system participates in hippocampus CA1 neuronal death of SHRSP following transient forebrain ischaemia. Clin Exp Pharmacol Physiol 1995, 22:S277-S278.
68. Zhang WW, Badonic T, Hoog A, Jiang MH, Ma KC, Nie XJ, Olsson Y: Astrocytes in Alzheimer's disease express immunoreactivity to the vasoconstrictor endothelin-1. J Neurol Sci 1994, 122:90-96.
69. Josko J: Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res 2003, 981:58-69.
70. Dirnagl D, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
71. Vexler ZS, Ferriero DM: Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol 2001, 6:99-108.
72. Marks N, Berg MJ: Recent advances on neuronal caspases in development and neurodegeneration. Neurochem Int 1999, 35:195-220.
73. Han BH, D'Costa A, Back SA, Parsadanian M, Shah AR, Gidday JM, Srinivasan A, Deshmukh M, Holtzman DM: BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 2000, 7:38-53.
74. Felderhoff-Mueser U, Taylor DL, Greenwood K, Kozma M, Stibenz D, Joashi UC, Edwards AD, Mehmet H: Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol 2000, 10:17-29.
75. Lipton JM, Catania A: Anti-inflammatory actions of the neuroimsmunomodulator alpha-MSH. Immunol Today 1997, 18:140-145.
76. Oktar BK, Ercan F, Yegen BC, Alican I: The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 2000, 21:1271-1277.
77. Rajora N, Boccoli G, Catania A, Lipton JM: alpha-MSH modulates experimental inflammatory bowel disease. Peptides 1997, 18:381-385.
78. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, Kelly L, Zhao H, Ichiyama T, Catania A, Lipton JM: alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 1999, 276:R1289-1294.
79. Redondo P, Garcia-Foncillas J, Okroujnov I, Bandres E: Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 1998, 290:425-428.
80. Magnoni S, Stocchetti N, Colombo G, Carlin A, Colombo A, Lopton JM, Catania A: Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma 2003, 20:251-260.
81. Lipton JM, Catania A, Delgado R: Peptide modulation of inflammatory processes Peptide modulation of inflammatory processes within the brain. Neuroimmunomodulation 1998, 5:178-83.
82. Catania A, Lipton JM: Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci 1998, 856:62-68.
83. Lipton JM, Catania A: Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci 1998, 1:373-380.
84. Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM: A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 1997, 4:37-41.
85. Dammann O, Kuban KCK, Leviton A: Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitation in children born preterm. Ment Retard Dev Disabil Res Rev 2002, 8:46-50.
86. Aubert A, Vega C, Dantzer R, Goodall G: Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun 1995, 9:129-148.